R Yamaguchi Selected Research

R Yamaguchi Research Topics

Disease

6	Neoplasms (Cancer) 10/2016 - 07/2000
3	Carcinoma (Carcinomatosis) 01/2019 - 07/2000
3	Inflammation (Inflammations) 08/2016 - 02/2000
3	Infections 02/2016 - 02/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016 - 07/2000
2	Malnutrition (Nutritional Deficiencies) 03/2011 - 10/2000
2	Obesity 03/2011 - 10/2010
2	Carcinogenesis 07/2000 - 07/2000
1	Severe Acute Respiratory Syndrome 11/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 02/2020
1	Amyloid Plaque 01/2019
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 06/2018
1	Squamous Cell Carcinoma of Head and Neck 10/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 02/2016
1	Hematologic Neoplasms (Hematological Malignancy) 09/2015
1	Glomerulonephritis 08/2014
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2012
1	Hyperphagia (Overeating) 03/2011
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2011
1	Birth Weight (Birth Weights) 10/2010
1	Hemorrhage 11/2007
1	Dental Caries (Decay, Dental) 01/2003
1	Malignant Mixed Tumor (Tumor, Malignant Mixed) 11/2001
1	Adenoma (Adenomas) 11/2001
1	Seminoma 08/2001
1	Testicular Neoplasms (Testicular Cancer) 08/2001
1	Paralysis (Palsy) 05/2001
1	Cyanosis 05/2001
1	Encephalomyelitis (Myeloencephalitis) 11/2000
1	Esophageal Neoplasms (Esophageal Cancer) 10/2000
1	Hepatocellular Carcinoma (Hepatoma) 07/2000
1	Stress Urinary Incontinence 05/2000
1	Osteomyelitis 05/2000
1	Arbovirus Infections 02/2000
1	Atrophy 02/2000
1	Hydranencephaly 02/2000
1	Cataract (Cataracts) 02/2000

Drug/Important Bio-Agent (IBA)

3	Cyclin AIBA 08/2001 - 07/2000
2	AcidsIBA 08/2016 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 07/2000 - 07/2000
1	OzoneIBA 11/2021
1	LithiumIBA 01/2021
1	Methenamine (Hexamine)IBA 02/2020
1	AmelogeninIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Hormones (Hormone)IBA 06/2018
1	Factor VaIBA 10/2016
1	deoxyhypusine synthaseIBA 10/2016
1	hypusineIBA 10/2016
1	AntigensIBA 02/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 08/2014
1	Peptides (Polypeptides)IBA 03/2011
1	GhrelinIBA 03/2011
1	Messenger RNA (mRNA)IBA 10/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2010
1	Nonesterified Fatty Acids (NEFA)IBA 10/2010
1	Triglycerides (Triacylglycerol)IBA 10/2010
1	Hematoxylin (Haematoxylon)IBA 11/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2007
1	erybraedin AIBA 11/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2003
1	PhytochemicalsIBA 01/2003
1	erycristagallinIBA 01/2003
1	Bone Morphogenetic Protein 6IBA 11/2001
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2001
1	8-hydroxyguanineIBA 09/2001
1	CyclinsIBA 08/2001
1	aniline (aniline hydrobromide)IBA 05/2001
1	Viral AntigensIBA 11/2000
1	Ethanol (Ethyl Alcohol)IBA 10/2000
1	CarcinogensIBA 10/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2000
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2000
1	Cyclin D1IBA 07/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2000
1	SuspensionsIBA 05/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2000
1	AntibodiesIBA 02/2000
1	Retinaldehyde (Retinal)IBA 02/2000
1	Green Fluorescent ProteinsIBA 02/2000

Therapy/Procedure

1	Mandibular Osteotomy 01/2019
1	Hematopoietic Stem Cell Transplantation 09/2015
1	Electrodes (Electrode) 02/2012
1	Suture Anchors 05/2000